We are live on ! Find out more
SGCM

Sand Grove Capital Management Portfolio holdings

AUM $444M
1-Year Est. Return 131.11%
This Fund
S&P 500
This Quarter Est. Return
+2.41%
1 Year Est. Return
+131.11%
3 Year Est. Return
+410.73%
5 Year Est. Return
+1,022.21%
10 Year Est. Return
+24,985.77%
AUM
$342M
AUM Growth
-$95.1M
Cap. Flow
-$87.8M
Cap. Flow %
-25.67%
Top 10 Hldgs %
78.59%
Holding
33
New
11
Increased
2
Reduced
7
Closed
13

Sector Composition

Rank Sector Weight
1 Healthcare 35.04%
2 Energy 17.88%
3 Industrials 14.85%
4 Consumer Staples 12.09%
5 Technology 8.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OLK
26
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
-427,950
Closed -$10.1M
EVBG
27
DELISTED
Everbridge, Inc. Common Stock
EVBG
-596,137
Closed -$20.8M
FUSN
28
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
-490,547
Closed -$10.5M
DOOR
29
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
-80,825
Closed -$10.6M
PXD
30
DELISTED
Pioneer Natural Resource Co.
PXD
-186,977
Closed -$49.1M
NGMS
31
DELISTED
NeoGames S.A. Ordinary Shares
NGMS
-996,155
Closed -$28.8M
EGLE
32
DELISTED
Eagle Bulk Shipping Inc.
EGLE
-112,432
Closed -$7.02M
VZIO
33
DELISTED
VIZIO Holding Corp.
VZIO
-1,915,994
Closed -$21M

Similar funds

Sand Grove Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Sand Grove Capital Management held 33 positions worth $342M, down 22% from $437M the previous quarter. Its ten largest holdings account for 79% of the portfolio.

Sand Grove Capital Management withdrew a net $87.8M in Q2 2024, closing 13 positions and reducing 7 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $49.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 12% a quarter earlier, followed by Energy and Industrials.

Against the trend, Sand Grove Capital Management opened a new position in Cerevel Therapeutics Holdings, Inc. Common Stock worth $37.6M.

  • Sand Grove Capital Management's largest Q2 2024 buy was Cerevel Therapeutics Holdings, Inc. Common Stock: 919,023 shares worth $37.6M.
  • Sand Grove Capital Management added most to Amedisys in Q2 2024, an estimated $17.5M increase.
  • Sand Grove Capital Management's biggest Q2 2024 reduction was US Steel, cutting an estimated $14.8M.
  • Sand Grove Capital Management fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $49.1M.
  • Sand Grove Capital Management's ten largest holdings make up 79% of its $342M portfolio in Q2 2024.
  • Sand Grove Capital Management opened 11 new positions and closed 13 in Q2 2024.
  • Sand Grove Capital Management's portfolio value fell 22% quarter-over-quarter to $342M.

Based on Sand Grove Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.